{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:12:42Z","timestamp":1791475962778,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00228-019-02746-6","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:02:19Z","timestamp":1566241339000},"page":"1599-1615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Suspected adverse reactions associated with herbal products used for weight loss: spontaneous reports from the Italian Phytovigilance System"],"prefix":"10.1007","volume":"75","author":[{"given":"Gabriela","family":"Mazzanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-9755","authenticated-orcid":false,"given":"Annabella","family":"Vitalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Da Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menniti-Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"2746_CR1","unstructured":"World Health Organization (WHO) (2017) Overweight and obesity. \nhttp:\/\/www.who.int\/gho\/ncd\/risk_factors\/overweight\/en\/\n\n Accessed 17 Oct 2018"},{"key":"2746_CR2","unstructured":"World Health Organization (WHO) (2018) Overweight and obesity. \nhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/\n\n Accessed 17 Oct 2018"},{"issue":"4","key":"2746_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/2042098613489721","volume":"4","author":"BM Cheung","year":"2013","unstructured":"Cheung BM, Cheung TT, Samaranayake NR (2013) Safety of antiobesity drugs. Ther Adv Drug Saf 4(4):171\u2013181","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"2746_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1373\/clinchem.2017.272815","volume":"64","author":"KM Gadde","year":"2018","unstructured":"Gadde KM, Apolzan JW, Berthoud HR (2018) Pharmacotherapy for patients with obesity. Clin Chem 64(1):118\u2013129","journal-title":"Clin Chem"},{"issue":"1","key":"2746_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/nyas.13542","volume":"411","author":"A Velazquez","year":"2018","unstructured":"Velazquez A, Apovian CM (2018) Updates on obesity pharmacotherapy. Ann N Y Acad Sci 411(1):106\u2013119","journal-title":"Ann N Y Acad Sci"},{"key":"2746_CR6","unstructured":"Consumer Goods & FMCG; Food & Nutrition. Sales volume of dietary supplements in Italy between 2008 and March 2017 (in million packs). Statista 2018. \nhttps:\/\/www.statista.com\/statistics\/783675\/sales-volume-of-dietary-supplements-in-italy\/\n\n. Accessed 26 Nov 2018"},{"issue":"6","key":"2746_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/pds.1566","volume":"7","author":"F Menniti-Ippolito","year":"2008","unstructured":"Menniti-Ippolito F, Mazzanti G, Santuccio C, Moro PA, Calapai G, Firenzuoli F, Valeri A, Raschetti R (2008) Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf 7(6):626\u2013635","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2746_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/bcp.12976","volume":"83","author":"SW Lee","year":"2017","unstructured":"Lee SW, Lai NM, Chaiyakunapruk N, Chong DW (2017) Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review. Br J Clin Pharmacol 83(1):172\u2013179","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2746_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.28813","volume":"65","author":"VJ Navarro","year":"2017","unstructured":"Navarro VJ, Khan I, Bj\u00f6rnsson E, Seeff LB, Serrano J, Hoofnagle JH (2017) Liver injury from herbal and dietary supplements. Hepatology 65(1):363\u2013373","journal-title":"Hepatology"},{"issue":"4","key":"2746_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/bcp.13171","volume":"83","author":"G Mazzanti","year":"2017","unstructured":"Mazzanti G, Moro PA, Raschi E, Da Cas R, Menniti-Ippolito F (2017) Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system. Br J Clin Pharmacol 83(4):894\u2013908","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2746_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1060028017744316","volume":"52","author":"BB Timbo","year":"2017","unstructured":"Timbo BB, Chirtel SJ, Ihrie J, Oladipo T, Velez-Suarez L, Brewer V, Mozersky R (2017) A review of dietary supplement adverse event report data from the FDA Center for food safety and applied nutrition adverse event reporting system (CAERS), 2004-2013. Ann Pharmacother 52(5):431\u2013438","journal-title":"Ann Pharmacother"},{"issue":"16","key":"2746_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","volume":"373","author":"AI Geller","year":"2015","unstructured":"Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, Mozersky RP, Budnitz DS (2015) Emergency department visits related to dietary supplements. N Engl J Med 373(16):1531\u20131540","journal-title":"N Engl J Med"},{"issue":"3","key":"2746_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00228-010-0981-4","volume":"67","author":"A Vitalone","year":"2011","unstructured":"Vitalone A, Menniti-Ippolito F, Moro PA, Firenzuoli F, Raschetti R, Mazzanti G (2011) Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of health. Eur J Clin Pharmacol 67(3):215\u2013224","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2746_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf 20(2):109\u2013117","journal-title":"Drug Saf"},{"key":"2746_CR15","unstructured":"World Health Organization (2004) WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. \nhttp:\/\/www.appswhoint\/medicinedocs\/documents\/s7148e\/s7148epdf\n\n Accessed 24 Oct 2018"},{"key":"2746_CR16","unstructured":"The Uppsala Monitoring Center. The use of the WHO-UMC system for standardised case causality assessment. \nhttp:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/WHOcausality_assessment.pdf\n\n. Accessed 26 Nov 2018"},{"key":"2746_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323\u20131330","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2746_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jceh.2014.03.040","volume":"4","author":"NS Choudhary","year":"2014","unstructured":"Choudhary NS, Kotecha H, Saraf N, Gautam D, Saigal S (2014) Terbinafine induced liver injury: a case report. J Clin Exp Hepatol 4(3):264\u2013265","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"2746_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0002-9343(76)90564-7","volume":"60","author":"JS Rodman","year":"1976","unstructured":"Rodman JS, Deutsch DJ, Gutman SI (1976) Methyldopa hepatitis. A report of six cases and review of the literature. Am J Med 60(7):941\u2013948","journal-title":"Am J Med"},{"issue":"10","key":"2746_CR20","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.dld.2006.10.002","volume":"39","author":"GC Actis","year":"2007","unstructured":"Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M (2007) Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis 39(10):953\u2013955","journal-title":"Dig Liver Dis"},{"key":"2746_CR21","doi-asserted-by":"publisher","first-page":"6483605","DOI":"10.1155\/2018\/6483605","volume":"2018","author":"JP Kothadia","year":"2018","unstructured":"Kothadia JP, Kaminski M, Samant H, Olivera-Martinez M (2018) Hepatotoxicity associated with use of the weight loss supplement Garcinia Cambogia: a case report and review of the literature. Case Reports Hepatol 2018:6483605","journal-title":"Case Reports Hepatol"},{"issue":"6","key":"2746_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11739-018-1880-4","volume":"13","author":"G Crescioli","year":"2018","unstructured":"Crescioli G, Lombardi N, Bettiol A, Marconi E, Risaliti F, Bertoni M, Menniti-Ippolito F, Maggini V, Gallo E, Firenzuoli F, Vannacci A (2018) Acute liver injury following Garcinia cambogia weight-loss supplementation: case series and literature review. Intern Emerg Med 13(6):857\u2013872","journal-title":"Intern Emerg Med"},{"issue":"8","key":"2746_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40264-016-0428-7","volume":"39","author":"EX Zheng","year":"2016","unstructured":"Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, Navarro VJ (2016) Risk of liver injury associated with green tea extract in SLIMQUICK(\u00ae) weight loss products: results from the DILIN prospective study. Drug Saf 39(8):749\u2013754","journal-title":"Drug Saf"},{"issue":"4","key":"2746_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","volume":"65","author":"G Mazzanti","year":"2009","unstructured":"Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S (2009) Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65(4):331\u2013341","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"2746_CR25","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00204-015-1521-x","volume":"89","author":"G Mazzanti","year":"2015","unstructured":"Mazzanti G, Di Sotto A, Vitalone A (2015) Hepatotoxicity of green tea: an update. Arch Toxicol 89(8):1175\u20131191","journal-title":"Arch Toxicol"},{"key":"2746_CR26","unstructured":"Food and Drug Administration (2018) DMAA in Products Marketed as Dietary Supplements 2018. \nhttps:\/\/www.fda.gov\/Food\/DietarySupplements\/ProductsIngredients\/ucm346576.htm#warning_letters\n\n. Accessed 24 Oct 2018"},{"issue":"1","key":"2746_CR27","doi-asserted-by":"publisher","first-page":"111.e3","DOI":"10.1016\/j.ajem.2013.08.042","volume":"32","author":"C Campana","year":"2014","unstructured":"Campana C, Griffin PL, Simon EL (2014) Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure. Am J Emerg Med 32(1):111.e3\u2013111.e4","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2746_CR28","first-page":"138","volume":"47","author":"DJ Sung","year":"2018","unstructured":"Sung DJ, Choi EJ, Kim S, Kim J (2018) Rhabdomyolysis from resistance exercise and caffeine intake. Iran J Public Health 47(1):138\u2013139","journal-title":"Iran J Public Health"},{"issue":"5","key":"2746_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2169\/internalmedicine.46.1893","volume":"46","author":"Y Takeuchi","year":"2007","unstructured":"Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K (2007) Insulin autoimmune syndrome possibly caused by alpha lipoic acid. Intern Med 46(5):237\u2013239","journal-title":"Intern Med"},{"issue":"3","key":"2746_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.diabres.2006.07.005","volume":"75","author":"N Furukawa","year":"2007","unstructured":"Furukawa N, Miyamura N, Nishida K, Motoshima H, Taketa K, Araki E (2007) Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract 75(3):366\u2013367","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2746_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/cen.12334","volume":"81","author":"D Gullo","year":"2014","unstructured":"Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R (2014) Insulin autoimmune syndrome (Hirata disease) in European Caucasians taking \u03b1-lipoic acid. Clin Endocrinol 81(2):204\u2013209","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2746_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.medcli.2014.02.013","volume":"144","author":"T Michalopoulou Alevras","year":"2015","unstructured":"Michalopoulou Alevras T, Guerrero Gual M, Villabona Artero C, P\u00e9rez-Maraver M (2015) Autoimmune hypoglycemia syndrome associated with \u03b1 lipoic acid consumption. Med Clin 144(2):93\u201394","journal-title":"Med Clin"},{"issue":"2","key":"2746_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.joim.2019.01.009","volume":"17","author":"R Farrington","year":"2019","unstructured":"Farrington R, Musgrave IF, Byard RW (2019) Evidence for the efficacy and safety of herbal weight loss preparations. J Integr Med 17(2):87\u201392","journal-title":"J Integr Med"},{"issue":"7","key":"2746_CR34","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/ijc.22485","volume":"120","author":"TR Rebbeck","year":"2007","unstructured":"Rebbeck TR, Troxel AB, Norman S, Bunin GR, De Michele A, Baumgarten M, Berlin M, Schinnar R, Strom BL (2007) A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer 120(7):1523\u20131528","journal-title":"Int J Cancer"},{"issue":"1","key":"2746_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.je.2016.08.004","volume":"27","author":"LG Zhao","year":"2017","unstructured":"Zhao LG, Li HL, Sun JW, Yang Y, Ma X, Shu XO, Zheng W, Xiang YB (2017) Green tea consumption and cause-specific mortality: results from two prospective cohort studies in China. J Epidemiol 27(1):36\u201341","journal-title":"J Epidemiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T23:20:29Z","timestamp":1597706429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02746-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u201cThis article does not contain any studies with human participants or animals performed by any of the authors.\u201d","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}